Drug details

FluMist 2022-2023 Formula (influenza vaccine live, intranasal intranasal spray)

type of Vaccines, Live, Viral

FluMist Quadrivalent (influenza vaccine live, intranasal) Intranasal Spray 2022-2023 is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FluMist Quadrivalent is approved for use in persons 2 through 49 years of age.

This drug may have the following side effects:

• headache,
• sore throat,
• irritability,
• lethargy,
• decreased appetite,
• muscle aches, and
• runny nose or nasal congestion,
• fever over 100°F (37.8°C),
• chills.

The following drugs are related to FluMist 2022-2023 Formula, either as a replacement or used together:

• Afluria (influenza virus vaccine)
• Fluzone Highdose (flu vaccine)
• Flublok (influenza vaccine for intramuscular injection)
• Flucelvax (influenza virus vaccine for injection)
• Fludara (fludarabine)
• Fluzone (influenza virus vaccine)
• Tamiflu (oseltamivir phosphate)